Business Context and Reporting Period
This Form 6-K filing by Sanofi-Aventis (Sanofi) covers the month of February 2010. The report serves to incorporate by reference three press releases issued between late January and February 10, 2010, detailing strategic transactions and the company's full-year 2009 financial results.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.3) regarding the 2009 annual financial results, which is referenced but not reproduced in the provided text.
Material Changes and Strategic Transactions
- China Joint Venture: On January 29, 2010, Sanofi signed agreements to establish a new consumer healthcare joint venture in China with Minsheng Pharmaceutical Group.
- Chattem Acquisition: On February 9, 2010, the company successfully completed a tender offer for Chattem, Inc.
- 2009 Results: The company released its annual financial results for the fiscal year 2009 on February 10, 2010.
Guidance, Outlook, and Risks
The provided text does not contain specific management commentary, forward-looking guidance, risk factors, or details on contingencies. These elements are expected to be found in the full text of the referenced press releases (Exhibits 99.1 through 99.3).
Investor Verification Checklist
- Review Exhibit 99.3 for specific 2009 revenue, net income, and cash flow figures.
- Verify the financial terms and strategic rationale of the Chattem, Inc. tender offer completion.
- Examine the structure and ownership split of the new consumer healthcare joint venture in China.
- Check for any updated 2010 guidance or outlook provided in the February 10 press release.